AU3670697A - Recombinant pox virus for immunization against tumor-associated antigens - Google Patents

Recombinant pox virus for immunization against tumor-associated antigens

Info

Publication number
AU3670697A
AU3670697A AU36706/97A AU3670697A AU3670697A AU 3670697 A AU3670697 A AU 3670697A AU 36706/97 A AU36706/97 A AU 36706/97A AU 3670697 A AU3670697 A AU 3670697A AU 3670697 A AU3670697 A AU 3670697A
Authority
AU
Australia
Prior art keywords
associated antigens
against tumor
pox virus
immunization against
recombinant pox
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU36706/97A
Other versions
AU718945B2 (en
Inventor
Dennis L. Panicali
Nicholas Restifo
Steven A Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Therion Biologics Corp
Original Assignee
US Department of Health and Human Services
Therion Biologics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, Therion Biologics Corp filed Critical US Department of Health and Human Services
Publication of AU3670697A publication Critical patent/AU3670697A/en
Application granted granted Critical
Publication of AU718945B2 publication Critical patent/AU718945B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001136—Cytokines
    • A61K39/00114—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A61K39/001191—Melan-A/MART
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A61K39/001192—Glycoprotein 100 [Gp100]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
AU36706/97A 1996-07-25 1997-07-09 Recombinant pox virus for immunization against tumor-associated antigens Ceased AU718945B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68628196A 1996-07-25 1996-07-25
US08/686281 1996-07-25
PCT/US1997/012546 WO1998004728A1 (en) 1996-07-25 1997-07-09 Recombinant pox virus for immunization against tumor-associated antigens

Publications (2)

Publication Number Publication Date
AU3670697A true AU3670697A (en) 1998-02-20
AU718945B2 AU718945B2 (en) 2000-05-04

Family

ID=24755677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36706/97A Ceased AU718945B2 (en) 1996-07-25 1997-07-09 Recombinant pox virus for immunization against tumor-associated antigens

Country Status (5)

Country Link
EP (1) EP0951559A1 (en)
JP (1) JP2000515759A (en)
AU (1) AU718945B2 (en)
CA (1) CA2261990A1 (en)
WO (1) WO1998004728A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711957D0 (en) * 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
WO2000020027A2 (en) 1998-10-05 2000-04-13 M & E Biotech A/S Methods for therapeutic vaccination
ATE391726T1 (en) * 1999-10-22 2008-04-15 Sanofi Pasteur Ltd MODIFIED GP100 AND ITS USE
PT1282702E (en) 2000-05-10 2007-02-28 Ludwig Inst Cancer Res Immunogenic polypeptides encoded by mage minigenes and uses thereof
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
WO2003085087A2 (en) 2002-04-09 2003-10-16 Aventis Pasteur, Limited Modified cea nucleic acid and expression vectors
CN1596126A (en) 2001-11-30 2005-03-16 埃西斯创新有限公司 Vaccine
CA2550583C (en) 2003-10-08 2013-01-15 Sanofi Pasteur, Inc. Modified cea /b7 vector

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE197765T1 (en) * 1994-10-03 2000-12-15 Us Gov Health & Human Serv COMPOSITION CONTAINING AN ANTIGEN-EXPRESSING RECOMBINANT VIRUS AND AN IMMUNO-STIMULATING MOLECULE-EXPRESSING RECOMBINANT VIRUS
WO1996011279A2 (en) * 1994-10-03 1996-04-18 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system

Also Published As

Publication number Publication date
CA2261990A1 (en) 1998-02-05
EP0951559A1 (en) 1999-10-27
JP2000515759A (en) 2000-11-28
AU718945B2 (en) 2000-05-04
WO1998004728A1 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
CA2261989A1 (en) Recombinant pox virus for immunization against tumor-associated antigens
AU6095696A (en) Immunogenic peptides of prostate specific antigen
HK1083026A1 (en) Tumor-associated antigen derivatives from the mage family, used for the preparation of fusion proteins with t-helper epitopes and of compositions for vaccination
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
AU1914595A (en) Isolated antigenic oncogene peptide fragments and uses
AU3150295A (en) Dna vaccines against rotavirus infections
AU2158995A (en) Compositions and methods for vaccines comprising alpha-galactosyl epitopes
AU7706098A (en) Antigen delivery system
AU3119895A (en) Recombinant virus vectors
AU3407197A (en) Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
NZ298224A (en) Recombinant papilloma virus antigens
AU6976596A (en) Immunotherapeutic methods using tumor antigenic peptides coated on cells and vaccines made thereof
AU3670697A (en) Recombinant pox virus for immunization against tumor-associated antigens
AU2645297A (en) Hepatitis b monoclonal antibodies
AU1865297A (en) Methods and nucleic immunogenic compositions encoding antigens and co-stimulatory molecules for immunization
AU5021796A (en) Recombinant human anti-lewis b antibodies
AU2596397A (en) Monoclonal antibody that detects apoptotic antigen
AU7572198A (en) Tumor-associated antigen
AU2994599A (en) Active immunization against angiogenesis-associated antigens
AU3283500A (en) Tumor-associated antigen
AU2540897A (en) Methods and compositions of chimeric polypeptides for tumor antigen vaccines
AU6969798A (en) (pasteurella haemolytica) vaccine
AU7471098A (en) Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents
AU5851296A (en) Malaria peptides and vaccines
AU1809695A (en) Tumor associated monoclonal antibody 123av16

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired